Itafos Reports Q2 2026 Financial Results and Operational Highlights
Itafos reported record production but faced margin collapse and MgO project delays, adding execution risk to its operations.
Itafos Inc. (IFOS) reported second-quarter 2026 results showing revenue of $144.0 million, a 14% increase year-over-year, but a net loss of $(5.6) million compared to net income of $24.8 million a year ago. Adjusted EBITDA fell to $17.8 million from $31.8 million, driven by a spike in sulfur and sulfuric acid costs and the closure of the Strait of Hormuz. For the first half of 2026, the company posted a net loss of $(3.9) million and free cash flow of $(6.1) million.
Management raised the low end of full-year 2026 sales volume guidance to 340,000 tonnes of P2O5 and trimmed the high end of maintenance capital expenditures to $28 million. The MgO Reduction Project has been delayed to the 2028 turnaround, with capital costs rising to $95–110 million from the original estimate of $80–95 million. The company’s balance sheet shows net debt rising to $31.2 million with net leverage at 0.3x, while liquidity stands at $133.3 million.
Itafos Inc. (IFOS) reported second-quarter 2026 results that reinforce the severe margin compression previously indicated in the first quarter. The company swung to a net loss, driven in part by significant delays and cost overruns on its key MgO project.
While the balance sheet remains low-levered, free-cash-outflow for the first half of the year and rising net debt suggest these headwinds are not yet reflected in guidance metrics other than capital expenditures. The market had already repriced the shares from $4.40 in March to $2.24 prior to the release, indicating that part of the weakness was already priced in. However, the MgO delay introduces execution risk that was not previously contemplated, marking the release as materially negative.
Itafos Inc. (IFOS) is a pure-play phosphate fertilizer producer operating its flagship Conda facility in Idaho, USA, which manufactures monoammonium phosphate (MAP), sulfuric acid, and ammonia. The company’s Arraias operation in Brazil produces diammonium phosphate (DAPR), phosphoric acid (PAPR), G-PAPR, and excess sulfuric acid, with a restart of its single superphosphate (SSP) line scheduled for 2027. Additional assets include the undeveloped Farim phosphate rock project in Guinea-Bissau and the Santana high-grade resource in Brazil. Regarding offtake arrangements, J.R. Simplot purchases 100% of Conda’s MAP production, while approximately 60% of the company’s sulfuric acid is sourced from Rio Tinto under a long-term contract.